Related references
Note: Only part of the references are listed.Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation
Frank Niessen et al.
NATURE (2008)
Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells
T. Albrektsen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking
D. M. Monroe et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor
Haiwang Tang et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Clinical epidemiology of acute lung injury and acute respiratory distress syndrome: Incidence, diagnosis, and outcomes
Jaime F. Avecillas et al.
CLINICS IN CHEST MEDICINE (2006)
Emerging insights in tissue factor-dependent signaling events
HH Versteeg et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
Tissue factor in infection and severe inflammation
M Levi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
Pharmacological inhibition of tissue factor
PF Laterre et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial
E Abraham et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model
R Pawlinski et al.
BLOOD (2003)
Blockade of tissue factor - Treatment for organ injury in established sepsis
MS Carraway et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons
KE Welty-Wolf et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
High-dose a randomized antithrombin III in severe sepsis -: A randomized controlled trial
BL Warren et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Pharmacokinetics and safety of FFR-rFVIIa after single doses in healthy subjects
E Erhardtsen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Tissue factor-dependent factor VIIa signaling
LC Petersen et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2000)